Top

Pituitary

Published in:

17-10-2023 | Craniopharyngioma

The impact of facility type and volume on treatment and overall survival in craniopharyngioma

Authors: Benjamin F. Bitner, Derek H. Liu, Madeline M. Nottoli, Sina J. Torabi, Frank P. K. Hsu, Edward C. Kuan

Published in: Pituitary | Issue 6/2023

Abstract

Background

Craniopharyngiomas are uncommon benign sellar and parasellar tumors with high overall survival (OS) and recurrence rates. Treatment is often surgical but may include adjuvant therapies. The impact of adjuvant therapy and surgical approach have been evaluated, however, facility volume and type have not. The purpose of this study is to analyze the influence of facility volume and type on treatment modalities, extent of surgery and survival of craniopharyngioma.

Methods

The 2004–2016 National Cancer Database (NCDB) was queried for patients diagnosed with craniopharyngioma. Facilities were classified by type (academic vs. non-academic) and low-volume center (LVC) (Treating < 8 patients over the timeline) versus high-volume center (HVC), (Treating ≥ 8 patients over the timeline). Differences in treatment course, outcomes, and OS by facility type were assessed.

Results

3730 patients (51.3% female) with mean age 41.2 ± 22.0 were included with a 5-year estimated OS of 94.8% (94.0–95.5%). 2564 (68.7%) patients were treated at HVC, of which 2142 (83.5%) were treated at academic facilities. Patients treated at HVC’s were more likely to undergo both surgery and radiation. Surgical approach at HVC was more likely to be endoscopic. Patients treated at HVC demonstrated significantly higher 5-year OS compared to patients treated at LVC (96% [95% CI 95.6–97.1% versus 91.2% [95% CI 89–92.7%] with lower risk of mortality (Hazard ratio [95% CI] = 0.69 [0.56–0.84]).

Conclusion

Treatment of craniopharyngioma at HVC compared to LVC is associated with improved OS, lower 30- and 90-day postoperative mortality risk, and more common use of both radiotherapy and endoscopic surgical approach.

Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primer 5(1):75. https://doi.org/10.1038/s41572-019-0125-9CrossRef

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89(4):547–551. https://doi.org/10.3171/jns.1998.89.4.0547CrossRefPubMed

Nielsen EH, Feldt-Rasmussen U, Poulsgaard L et al (2011) Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 104(3):755–763. https://doi.org/10.1007/s11060-011-0540-6CrossRefPubMed

Hill TK, Baine MJ, Verma V et al (2019) Patterns of care in pediatric craniopharyngioma: outcomes following definitive radiotherapy. Anticancer Res 39(2):803–807. https://doi.org/10.21873/anticanres.13178CrossRefPubMed

Rao YJ, Hassanzadeh C, Fischer-Valuck B et al (2017) Patterns of care and treatment outcomes of patients with craniopharyngioma in the national cancer database. J Neurooncol 132(1):109–117. https://doi.org/10.1007/s11060-016-2342-3CrossRefPubMed

Zhang C, Verma V, Lyden ER et al (2018) The Role of definitive radiotherapy in craniopharyngioma: a SEER analysis. Am J Clin Oncol 41(8):807–812. https://doi.org/10.1097/COC.0000000000000378CrossRefPubMed

Pang JC, Chung D, Ovakimyan A et al (2022) Characteristics and Outcomes in pediatric versus adult craniopharyngiomas: a systematic review and meta-analysis. 31st Annu Meet North Am Skull Base Soc. https://doi.org/10.1055/s-0042-1743663CrossRef

Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G (2015) Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab 100(2):467–474. https://doi.org/10.1210/jc.2014-3525CrossRefPubMed

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM et al (2018) Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol 178(1):93–102. https://doi.org/10.1530/EJE-17-0707CrossRefPubMed

10.

Lehrich BM, Goshtasbi K, Hsu FPK, Kuan EC (2021) Characteristics and overall survival in pediatric versus adult craniopharyngioma: a population-based study. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg. https://doi.org/10.1007/s00381-021-05094-yCrossRef

11.

Yang I, Sughrue ME, Rutkowski MJ et al (2010) Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 28(4):E5. https://doi.org/10.3171/2010.1.FOCUS09307CrossRefPubMed

12.

Lin LL, El Naqa I, Leonard JR et al (2008) Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr 1(2):126–130. https://doi.org/10.3171/PED/2008/1/2/126CrossRefPubMed

13.

Goshtasbi K, Vasudev M, Torabi SJ et al (2021) The influence of facility volume and type on esthesioneuroblastoma treatment and outcomes. Int Forum Allergy Rhinol Published online. https://doi.org/10.1002/alr.22948CrossRef

14.

Goshtasbi K, Abiri A, Lehrich BM, Haidar YM, Tjoa T, Kuan EC (2021) The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma. Head Neck. https://doi.org/10.1002/hed.26739CrossRefPubMedPubMedCentral

15.

Chen AY, Pavluck A, Halpern M, Ward E (2009) Impact of treating facilities’ volume on survival for early-stage laryngeal cancer. Head Neck 31(9):1137–1143. https://doi.org/10.1002/hed.21072CrossRefPubMed

16.

David JM, Ho AS, Luu M et al (2017) Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer 123(20):3933–3942. https://doi.org/10.1002/cncr.30843CrossRefPubMed

17.

Bitner BF, Lehrich BM, Abiri A, Yasaka TM, Hsu FPK, Kuan EC (2021) Characteristics and overall survival in pediatric versus adult pituitary adenoma: a national cancer database analysis. Pituitary. https://doi.org/10.1007/s11102-021-01146-3CrossRefPubMed

18.

Sharma A, Schwartz SM, Méndez E (2013) Hospital volume is associated with survival but not multimodality therapy in medicare patients with advanced head and neck cancer. Cancer 119(10):1845–1852. https://doi.org/10.1002/cncr.27976CrossRefPubMed

19.

Chen AY, Fedewa S, Pavluck A, Ward EM (2010) Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer 116(20):4744–4752. https://doi.org/10.1002/cncr.25364CrossRefPubMed

20.

Gourin CG, Stewart CM, Frick KD et al (2019) Association of hospital volume with laryngectomy outcomes in patients with larynx cancer. JAMA Otolaryngol—Head Neck Surg 145(1):62–70. https://doi.org/10.1001/jamaoto.2018.2986CrossRefPubMed

21.

Yoshida EJ, Luu M, David JM et al (2018) Facility volume and survival in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 100(2):408–417. https://doi.org/10.1016/j.ijrobp.2017.09.038CrossRefPubMed

22.

Cheung MC, Koniaris LG, Perez EA, Molina MA, Goodwin WJ, Salloum RM (2009) Impact of hospital volume on surgical outcome for head and neck cancer. Ann Surg Oncol 16(4):1001–1009. https://doi.org/10.1245/s10434-008-0191-9CrossRefPubMed

23.

Roman KM, Torabi SJ, Bitner BF et al (2023) The impact of facility type and volume on outcomes in head and neck mucosal melanoma. Otolaryngol Neck Surg 168(5):1079–1088. https://doi.org/10.1002/ohn.173CrossRef

24.

Awad M, Butterfield JT, Dhawan S, Tyler MA, Venteicher AS (2023) Prognostic factors and treatment impact on overall survival in adult craniopharyngioma. World Neurosurg 173:e132–e139. https://doi.org/10.1016/j.wneu.2023.02.020CrossRefPubMed

25.

Liu APY, Tung JYL, Ku DTL et al (2020) Outcome of Chinese children with craniopharyngioma: a 20-year population-based study by the Hong Kong Pediatric Hematology/Oncology Study Group. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 36(3):497–505. https://doi.org/10.1007/s00381-019-04480-xCrossRef

26.

Ouyang D, El-Sayed IH, Yom SS (2014) National trends in surgery for sinonasal malignancy and the effect of hospital volume on short-term outcomes. Laryngoscope 124(7):1609–1614. https://doi.org/10.1002/lary.24578CrossRefPubMed

27.

Teitelbaum JI, Issa K, Barak IR et al (2020) Sinonasal squamous cell carcinoma outcomes: does treatment at a high-volume center confer survival benefit? Otolaryngol - Head Neck Surg U S 163(5):986–991. https://doi.org/10.1177/0194599820935395CrossRef

28.

Abiri A, Roman KM, Latif K et al (2022) Endoscopic versus Nonendoscopic surgery for resection of craniopharyngiomas. World Neurosurg. https://doi.org/10.1016/j.wneu.2022.08.068CrossRefPubMed

29.

Li X, Wu W, Miao Q et al (2019) Endocrine and metabolic outcomes after transcranial and endoscopic endonasal approaches for primary resection of craniopharyngiomas. World Neurosurg 121:e8–e14. https://doi.org/10.1016/j.wneu.2018.08.092CrossRefPubMed

30.

Komotar RJ, Starke RM, Raper DMS, Anand VK, Schwartz TH (2012) Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg 77(2):329–341. https://doi.org/10.1016/j.wneu.2011.07.011CrossRefPubMed

31.

Mortini P, Losa M, Pozzobon G et al (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series: clinical article. J Neurosurg 114(5):1350–1359. https://doi.org/10.3171/2010.11.JNS10670CrossRefPubMed

32.

Mesman R, Westert GP, Berden BJMM, Faber MJ (2015) Why do high-volume hospitals achieve better outcomes? a systematic review about intermediate factors in volume-outcome relationships. Health Policy Amst Neth 119(8):1055–1067. https://doi.org/10.1016/j.healthpol.2015.04.005CrossRef

33.

PDQ Pediatric Treatment Editorial Board. Childhood Craniopharyngioma Treatment (PDQ®): Health Professional Version. In: PDQ Cancer Information Summaries. National Cancer Institute (US); 2002. http://www.ncbi.nlm.nih.gov/books/NBK65891/. Accessed 22 May 2023

34.

Zhu P, Du XL, Blanco AI et al (2020) Impact of facility type and volume in low-grade glioma outcomes. J Neurosurg 133(5):1313–1323. https://doi.org/10.3171/2019.6.JNS19409CrossRef

35.

Jimenez RB, Ahmed S, Johnson A et al (2021) Proton radiation therapy for pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 110(5):1480–1487. https://doi.org/10.1016/j.ijrobp.2021.02.045CrossRefPubMed

36.

Drapeau A, Walz PC, Eide JG et al (2019) Pediatric craniopharyngioma. Childs Nerv Syst 35(11):2133–2145. https://doi.org/10.1007/s00381-019-04300-2CrossRefPubMed

37.

Schoonbeek RC, Zwertbroek J, Plaat BEC et al (2021) Determinants of delay and association with outcome in head and neck cancer: a systematic review. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 47(8):1816–1827. https://doi.org/10.1016/j.ejso.2021.02.029CrossRef

38.

Ortiz Torres M, Shafiq I, Mesfin FB. Craniopharyngioma. In: StatPearls. StatPearls Publishing; 2023. http://www.ncbi.nlm.nih.gov/books/NBK459371/. Accessed 22 May 2023

39.

Naghavi AO, Echevarria MI, Strom TJ et al (2018) Patient choice for high-volume center radiation impacts head and neck cancer outcome. Cancer Med 7(10):4964–4979. https://doi.org/10.1002/cam4.1756CrossRefPubMedPubMedCentral

40.

Du AT, Pang JC, Victor R et al (2022) The influence of facility volume and type on skull base chordoma treatment and outcomes. World Neurosurg 166:e561–e567. https://doi.org/10.1016/j.wneu.2022.07.064CrossRefPubMed

41.

Zoicas F, Schöfl C (2012) Craniopharyngioma in adults. Front Endocrinol. https://doi.org/10.3389/fendo.2012.00046CrossRef

42.

Shiminski-Maher T, Rosenberg M (1990) Late effects associated with treatment of craniopharyngiomas in childhood. J Neurosci Nurs 22(4):220–226. https://doi.org/10.1097/01376517-199008000-00006CrossRefPubMed

43.

Park HJ, Dho YS, Kim JH, Kim JW, Park CK, Kim YH (2020) Recurrence rate and prognostic factors for the adult craniopharyngiomas in long-term follow-Up. World Neurosurg 133:e211–e217. https://doi.org/10.1016/j.wneu.2019.08.209CrossRefPubMed

44.

Goshtasbi K, Lehrich BM, Abouzari M et al (2020) Endoscopic versus nonendoscopic surgery for resection of pituitary adenomas: a national database study. J Neurosurg 134(3):816–824. https://doi.org/10.3171/2020.1.JNS193062CrossRefPubMedPubMedCentral

Title: The impact of facility type and volume on treatment and overall survival in craniopharyngioma
Authors: Benjamin F. Bitner
Derek H. Liu
Madeline M. Nottoli
Sina J. Torabi
Frank P. K. Hsu
Edward C. Kuan
Publication date: 17-10-2023
Publisher: Springer US
Keyword: Craniopharyngioma
Published in: Pituitary / Issue 6/2023
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI: https://doi.org/10.1007/s11102-023-01359-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2023

Metastases to the pituitary gland: insights from the German pituitary tumor registry

Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans

Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak

Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis

Assessment of forearm muscles with ultrasound shear wave elastography in patients with acromegaly

Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials